Kisspeptin-10 for fertility and testosterone: what the evidence says

What did @zdopingowani actually say?

Honestly, this is a tough one to fact-check. The transcript provided for this video is almost entirely incoherent, likely the result of a failed auto-transcription of Polish-language audio. What we can work with is the video's caption, which describes kisspeptin-10, its applications, and its side effects, along with hashtags pointing to TRT, fertility, testosterone, and post-cycle recovery ("odblok"). Based on that framing, this video appears to be explaining kisspeptin-10 as a tool for hormonal optimization, possibly as an alternative or complement to HCG in testosterone recovery protocols. We can't quote the creator directly because the transcript is gibberish. So this fact-check is built on what the caption signals and what the peptide community typically claims about kisspeptin-10.

Does the science back this up?

The short answer: kisspeptin is real, its biology is well-established, but clinical use in the form sold in peptide markets is nowhere near proven. Kisspeptin is a neuropeptide encoded by the KISS1 gene that acts on GnRH neurons in the hypothalamus, triggering downstream release of LH and FSH. That mechanism is not in dispute.

Research by Dhillo et al. (2005, Journal of Clinical Endocrinology and Metabolism) demonstrated that intravenous kisspeptin-54 robustly stimulated LH release in healthy men. Later work by Jayasena et al. (2014, Clinical Endocrinology) showed that kisspeptin-54 could stimulate sperm parameters in men with hypogonadotropic hypogonadism. The shorter fragment, kisspeptin-10, has similar receptor affinity in vitro but a much shorter half-life in vivo, which is a practical problem that peptide sellers rarely mention.

The jump from "kisspeptin works in a hospital infusion study" to "kisspeptin-10 vials from a research chemical supplier will restore your testosterone" is a large one. Bioavailability, dosing frequency, and product purity are all unresolved in real-world use.

What did they get wrong (or right)?

Without a clean transcript, we can't pin specific errors on the creator. But the hashtag framing tells a story. Pairing kisspeptin with "odblok" (post-cycle recovery), HCG, and TRT suggests the video is positioning this peptide as part of a HPTA restart protocol. That framing is popular in bodybuilding communities and it is not entirely without logic, because kisspeptin does sit upstream of the HPG axis. But here is where things go sideways.

• Kisspeptin-10 has a plasma half-life of roughly two to four minutes in humans, making subcutaneous self-administration a pharmacokinetically awkward choice compared to protocols studied in clinical settings.
• No randomized controlled trial has validated a kisspeptin-10 subcutaneous protocol for post-anabolic steroid recovery in otherwise healthy men. The fertility data is in men with documented hypogonadotropic hypogonadism, not suppressed-but-otherwise-healthy bodybuilders.
• HCG, which the hashtags also reference, acts directly on Leydig cells and has decades of clinical data. Treating kisspeptin-10 as equivalent or superior is speculative at this stage.

If the video gave credit to kisspeptin's legitimate role in reproductive endocrinology research, that part is fair. If it implied this is a proven, safe self-administration protocol, that part is not.

What should you actually know?

Kisspeptin is genuinely interesting science. It is not pseudoscience. But interesting science in a research context and "peptide you should inject for your post-cycle therapy" are two different things, and the gap between them matters for your health.

The peptide sold as kisspeptin-10 in gray-market research chemical stores has no guaranteed purity, no standardized dosing protocol supported by human trials, and no regulatory approval anywhere for the uses being described. The studies worth reading, including Skorupskaite et al. (2014, Human Reproduction Update), focus on endogenous kisspeptin signaling and pharmaceutical-grade infusion protocols, not self-administered vials.

If you are dealing with post-TRT suppression or fertility concerns, a reproductive endocrinologist can offer clomiphene, HCG, or FSH protocols with actual clinical evidence behind them. Kisspeptin-10 may eventually join that toolkit. Right now, it is not there yet. Treating a TikTok video as a protocol guide for hormonal recovery is a risk that the algorithm will not share with you.